Skip to content
OpenCapital
Get started

GitLab GTLB Concentration Risk %

Concentration Risk % at other companies

Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
36%+7.0pp
Strattec Security logo
Strattec SecuritySTRT
0.5%0.0pp

Segments

By product

See full
Subscription—self-managed57%-6.6%
SaaS33%+10.0%
License—self-managed7%0.0%
Professional services and other3%+50.0%

Other financials

Income statement

See full
Revenue$264.2M+23.1%
Gross profit$226.7M+19.6%
Operating income-$15.7M+54.5%
Net income-$5.0M+86.1%
EPS (diluted)-$0.03+86.4%

Balance sheet

See full
Cash & equivalents$335.4M+31.2%
Total debt$400.0K-20.0%
Total equity$985.2M+21.9%
Total assets$1.7B+18.3%

Cash flow

See full
Operating cash flow$149.2M+40.4%
CapEx$2.4M+162%
Free cash flow$146.8M+39.3%

Valuation

See full
Market cap$4.64B-31.0%
P/S4.6×-3.7×

Profitability

See full
Gross margin86.7%-1.9pp
Operating margin-5.1%-2.1pp
Net margin-2.5%—
FCF margin26.2%—

Returns & leverage

See full
Return on equity-2.8%—
Debt / equity0×0.0×
Current ratio2.5×+0.1×